111 related articles for article (PubMed ID: 23721187)
21. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
Sun W; Zhang N; Li A; Zou W; Xu W
Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
[TBL] [Abstract][Full Text] [Related]
23. Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy.
Li C; Cui J; Wang C; Li Y; Zhang H; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
Eur J Pharm Biopharm; 2008 Oct; 70(2):657-65. PubMed ID: 18582570
[TBL] [Abstract][Full Text] [Related]
24. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
25. Isolation, purification and identification of nine chemical compounds from Flammulina velutipes fruiting bodies.
Cai H; Liu X; Chen Z; Liao S; Zou Y
Food Chem; 2013 Dec; 141(3):2873-9. PubMed ID: 23871036
[TBL] [Abstract][Full Text] [Related]
26. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
27. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
[TBL] [Abstract][Full Text] [Related]
28. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
30. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study.
Bothiraja C; Yojana BD; Pawar AP; Shaikh KS; Thorat UH
Expert Opin Drug Deliv; 2014 Jan; 11(1):17-29. PubMed ID: 24294925
[TBL] [Abstract][Full Text] [Related]
31. Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma.
Wu G; Li J; Yue J; Zhang S; Yunusi K
Mol Med Rep; 2018 Feb; 17(2):2456-2464. PubMed ID: 29207088
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.
Nanjwade BK; Singh J; Parikh KA; Manvi FV
Int J Pharm; 2010 Jan; 385(1-2):176-80. PubMed ID: 19854254
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of superoxide dismutase in rats after oral administration.
Regnault C; Soursac M; Roch-Arveiller M; Postaire E; Hazebroucq G
Biopharm Drug Dispos; 1996 Mar; 17(2):165-74. PubMed ID: 8907723
[TBL] [Abstract][Full Text] [Related]
34. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
[TBL] [Abstract][Full Text] [Related]
35. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids.
Mo R; Sun Q; Li N; Zhang C
Biomaterials; 2013 Apr; 34(11):2773-86. PubMed ID: 23352118
[TBL] [Abstract][Full Text] [Related]
36. Chondroitin sulfate functionalized liposomes for solid tumor targeting.
Bagari R; Bansal D; Gulbake A; Jain A; Soni V; Jain SK
J Drug Target; 2011 May; 19(4):251-7. PubMed ID: 20545459
[TBL] [Abstract][Full Text] [Related]
37. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability.
Ryu JK; Yoo SD
Drug Dev Ind Pharm; 2012 Nov; 38(11):1313-8. PubMed ID: 22283588
[TBL] [Abstract][Full Text] [Related]
40. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
